Acorah Software Products - Accounts Production 15.0.600 false true true 31 March 2023 1 April 2022 false 1 April 2023 31 March 2024 31 March 2024 11630509 Mr David Ramsey Mr Liam O'Neill Professor Andrew Coats Mr Jason Powell the directors true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11630509 2023-03-31 11630509 2024-03-31 11630509 2023-04-01 2024-03-31 11630509 frs-core:CurrentFinancialInstruments 2024-03-31 11630509 frs-core:Non-currentFinancialInstruments 2024-03-31 11630509 frs-core:SharePremium 2024-03-31 11630509 frs-core:ShareCapital 2024-03-31 11630509 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 11630509 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 11630509 frs-bus:FilletedAccounts 2023-04-01 2024-03-31 11630509 frs-bus:SmallEntities 2023-04-01 2024-03-31 11630509 frs-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 11630509 frs-bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 11630509 1 2023-04-01 2024-03-31 11630509 frs-core:UnlistedNon-exchangeTraded 2024-03-31 11630509 frs-core:UnlistedNon-exchangeTraded 2023-03-31 11630509 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-03-31 11630509 frs-core:AdditionsToInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 11630509 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-03-31 11630509 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-03-31 11630509 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 11630509 frs-bus:Director1 2023-04-01 2024-03-31 11630509 frs-bus:Director2 2023-04-01 2024-03-31 11630509 frs-bus:Director3 2023-04-01 2024-03-31 11630509 frs-bus:Director4 2023-04-01 2024-03-31 11630509 frs-core:Non-currentFinancialInstruments 5 2024-03-31 11630509 frs-countries:EnglandWales 2023-04-01 2024-03-31 11630509 2022-03-31 11630509 2023-03-31 11630509 2022-04-01 2023-03-31 11630509 frs-core:CurrentFinancialInstruments 2023-03-31 11630509 frs-core:Non-currentFinancialInstruments 2023-03-31 11630509 frs-core:SharePremium 2023-03-31 11630509 frs-core:ShareCapital 2023-03-31 11630509 frs-core:RetainedEarningsAccumulatedLosses 2023-03-31 11630509 frs-core:Non-currentFinancialInstruments 5 2023-03-31
Registered number: 11630509
Radcliffe Group Ltd
Financial Statements
For The Year Ended 31 March 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 11630509
2024 2023
Notes £ £ £ £
FIXED ASSETS
Investments 4 217 200
217 200
CURRENT ASSETS
Debtors 5 81,023 166,158
Cash at bank and in hand 676 84,151
81,699 250,309
NET CURRENT ASSETS (LIABILITIES) 81,699 250,309
TOTAL ASSETS LESS CURRENT LIABILITIES 81,916 250,509
Creditors: Amounts Falling Due After More Than One Year 6 (253 ) (254 )
NET ASSETS 81,663 250,255
CAPITAL AND RESERVES
Called up share capital 7 217 217
Share premium account 251,685 251,685
Profit and Loss Account (170,239 ) (1,647 )
SHAREHOLDERS' FUNDS 81,663 250,255
Page 1
Page 2
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr David Ramsey
Director
Mr Liam O'Neill
Director
16 August 2024
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Radcliffe Group Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11630509 . The registered office is Unit F Bourne End Business Park, Cores End Road, Bourne End, Buckinghamshire, SL8 5AS.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements are prepared under the historical cost convention and in accordance with the FRS 102 Section 1A Small Entities - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
The Companies Act 2006 gives exemption from the requirement to prepare group accounts to groups that are defined to be small under the act. Therefore, Radcliffe Group have chosen to apply this exemption.
2.2. Going Concern Disclosure
The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern.
2.3. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
2.4. Group Accounts
The group is a small group as defined by the Companies Act 2006 s.399(2A) and therefore has chosen to take advantage of the exemption to prepare group accountants and therefore presents only it's own non-consolidated entity in these financial statements.
2.5. Registrar Filing Requirements
The company has taken advantage of Companies Act 2006 section 444(1) and opted not to file the profit and loss account, directors report, and notes to the financial statements relating to the profit and loss account.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 4 (2023: 4)
4 4
Page 3
Page 4
4. Investments
Unlisted
£
Cost
As at 1 April 2023 200
Additions 17
As at 31 March 2024 217
Provision
As at 1 April 2023 -
As at 31 March 2024 -
Net Book Value
As at 31 March 2024 217
As at 1 April 2023 200
The investments at the balance sheet date include the following:
100% of the share capital of Radcliffe Medical Media Ltd, a company registered in United Kingdom.
100% of the share capital of Radcliffe Medical Education Ltd, a company registered in United Kingdom.
100% of the share capital of Radcliffe Medical Communications Ltd, a company registered in Ireland.
5. Debtors
2024 2023
£ £
Due within one year
Corporation tax recoverable assets - 598
Amounts owed by group undertakings 81,023 165,560
81,023 166,158
6. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
Convertible Loan - Equity Shares 253 254
7. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 217 217
8. Dividends
During the year, there were no dividends paid (2023: £nil). 
9. Related Party Transactions
Radcliffe Medical Media Ltd
There is an amount owed from the wholly-owned subsidiary, Radcliffe Medical Media Ltd, at the year-end of £81,040 (2023: £165,760).
Radcliffe Medical Communications Ltd
On the 5th May 2023, Radcliffe Group Ltd incorporated a 100% owned subsidiary in Ireland, Radcliffe Medical Communications Ltd (740394). Share capital of 20 EUR (£17.09) was issued and remains unpaid on the intercompany account at the year-end.
Page 4
Page 5
10. Ultimate Controlling Party
The company's ultimate controlling parties are the directors by virtue of their ownership of the majority of the issued share capital in the company.
Page 5